The collagenous C-type lectin, SP-D, is a multitrimeric glycoprotein present at mucosal surfaces and is involved in host defense against infections in mammals. SP-D has immunomodulatory properties, but the underlying mechanisms are incompletely understood. SP-D contains collagen domains. LAIR-1 is an inhibitory immune receptor at the cell surface of various immunecompetent cells that binds collagen. We hypothesized that the immunomodulatory functions of SP-D can be mediated via interactions between its collagen domain and LAIR-1. Binding assays show that SP-D interacts via its collagenous domain with LAIR-1 and the related LAIR-2. This does not affect the mannan-binding capacities of SP-D, which induces cross-linking of LAIR-1 in a cellular reporter assay. Functional assays show that SP-D inhibits the production of Fc␣R-mediated reactive oxygen via LAIR-1. Our studies indicate that SP-D is a functional ligand of the immune inhibitory receptor LAIR-1. Thus, we have identified a novel pathway for the immunomodulatory functions of SP-D mediated via binding of its collagenous domains to LAIR-1. This may provide a mechanism for the unexplained immunomodulatory function of the collagenous domains of SP-D.
Introduction
The lung contains a large alveolar surface area that is constantly exposed to pathogens, such as viruses and bacteria.
SP-D belongs to the family of the "collectins" and functions as a first-line (innate) defense component that contributes to protection against pathogens in various mucosal tissues, such as the lung and gastrointestinal tract [1] . SP-D is composed of four domains: a short cysteine-rich N-terminal region, a 177-aalong collagenous domain, and an ␣-helical neck domain that links the collagen to a C-type lectin domain or CRD (see Fig.  1A ) [2] . One SP-D structural subunit is composed of three polypeptide chains, and these trimers assemble further into cruciform-like dodecamers [2] . SP-D functions as an opsonin by binding to various pathogens, such as influenza A virus, but it also binds to the LPS on the cell wall of Gram-negative bacteria (reviewed in ref. [3] ). Besides functioning as an opsonin, SP-D has immunomodulatory properties. In human systems, SP-D inhibits T cell proliferation, as well as IL-2 production in vitro [4, 5] . SP-D also functions as a chemoattractant and can modulate the surface expression of TLR4 (reviewed in refs. [3, 6] ). In a human epithelial airway model, SP-D-diminished suppollen particles induced IL-8 secretion [7] .
SP-D Ϫ/Ϫ mice show a clear defect in immune regulation, as the lungs show a state of constitutive immune activation. Innate immune cells in the lungs of SP-D Ϫ/Ϫ show abnormalities, such as the constitutive release of cytokines and an altered morphology. Despite the exaggerated inflammatory response, SP-D Ϫ/Ϫ mice have impaired host defense (reviewed in ref. [8] ). Attempts to correct the phenotype by administrating or overexpressing truncated forms of SP-D showed that the collagenous domain is essentially involved in immune homeostasis [9, 10] . There are several candidate receptors that may exert the immunomodulatory functions of SP-D. Most candidate receptors have been shown to bind SP-D via its CRD and require the presence of calcium ions. Gardai et al. [11] showed binding of SP-D to the inhibitory SIRP␣, resulting in a reduced capacity of alveolar macrophages to ingest apoptotic cells. Furthermore, SP-D binds to the SIRP␣ homologue SIRP␤, although the functionality of this binding remains unclear [12] . SP-D binds CD14 and rough LPS via the CRD, whereby the binding of SP-D to CD14 inhibits the binding of rough and smooth LPS [13] . SP-D has been shown to bind to calreticulin/CD91 on macrophages via its collagenous domain, resulting in increased chemotaxis [14] . SP-D function can be modulated through post-translational modification by NO. The altered structure then initiates a proinflammatory response via calreticulin/CD91 and p38 activation [14] . Despite the increasing number of SP-D-binding receptors, the mechanism via which SP-D exerts its immunoinhibitory role is unclear. LAIR-1 is an inhibitory immune receptor that is expressed on most immune cells for which collagens are high-affinity ligands [15] [16] [17] . LAIR is capable of binding multiple collagens, and different binding sites on collagens II and III have been mapped [18] . Upon collagen-mediated ligation, LAIR-1 inhibits various cellular functions, including maturation, proliferation, and degranulation of cells [19] . In this study, we set out to investigate whether the collagen-containing innate immune protein SP-D can exert its immunomodulatory functions via the inhibitory receptor LAIR-1.
MATERIALS AND METHODS

Cells
PLB-985 cells, a human myeloid leukemia cell line derived from HL-60, which were a kind gift from Dr. Timo van den Berg (Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam), and 2B4 NFAT-GFP T cell reporters were cultured as described [16, 20, 21] . For granulocytic differentiation, cells were exposed to 0.65% (v/v) DMF (Thermo Fisher Scientific, Waltham, MA, USA) for 4 -5 days. A stable LAIR-1-knockdown of PLB-985 was obtained by transducing a pSicoR vector containing a shRNA for LAIR-1. An empty vector control was constructed as well [22] .
Recombinant proteins and antibodies
Anti-LAIR-1 (Clone 8A8; IgG1) [23] and anti-SIRL [24] antibodies, rLAIR proteins [25] , rhSP-D, and a truncated NCRD trimeric fragment of hSP-D [26, 27] were produced and characterized as described previously. F(ab=) 2 fragments were made by using the Mouse IgG1 F(ab) and F(ab=) 2 Preparation Kit (Thermo Fisher Scientific). Collagen 1 was purchased from SigmaAldrich (St. Louis, MO, USA), BSA (fraction V) from Roche Diagnostics (Basel, Switzerland), and peroxidase-conjugated goat anti-hIgG (FC fragment-specific) from Jackson ImmunoResearch (Suffolk, UK). Serum-derived IgA was purchased from MP Biomedicals (Santa Ana, CA, USA). Collagen peptides were a part of collagen toolkits obtained from Richard Farndale (University of Cambridge, UK) [18] .
Binding ELISA
MaxiSorp plates (Thermo Fisher Scientific) were coated overnight at 4°C with 50 l/well collagen I (in 2 mM acetic acid in PBS), BSA (in PBS), or rhSP-D (in 10 mM carbonate buffer, pH 9.6). After four washings with PBS, 10 g LAIR-1-Fc or 0.63 g LAIR-2-Fc in PBS, supplemented with 1% BSA and 10 mM EDTA, was added and incubated for 30 min at RT (quantities of recombinant proteins had been established in pilot experiments). After washing, peroxidase-conjugated goat anti-hIgG (Fc fragment-specific; Jackson ImmunoResearch) was added for 60 min at RT. After three washes, 2,2=-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) reagent (100 l/well; Roche Diagnostics) was added, and color was allowed to develop. Measurements were performed at 405 nm.
Biacore
Surface plasmon resonance (Biacore Life Sciences, GE Healthcare, Buckinghamshire, UK)-binding studies were performed with the Biacore T100 system (Biacore, GE Healthcare). Approximately 1100 RU of SP-D in 10 mM MES buffer, pH 6.1, were immobilized on a series S CM5 sensor chip by the amine coupling kit, according to the manufacturer's instructions. After coupling, the chip was pulsed for 30 s with ethyl(dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide subsequently, followed by a 30-s pulse with ethanolamine. Analysis was performed in buffer [125 mM NaCl, 2.5 mM CaCl 2 Baseline stability was checked after every experiment. Proteins were injected until binding equilibrium was reached. Binding data were analyzed with Biacore T100 evaluation software (version 2.01). Affinity constants were determined by steady-state analysis. The affinity is calculated using GraphPad Prism (version 5.03). The formula used for a two-site-specific binding is:
, where X represents the ligand concentration in nM.
Mannan-immobilized SP-D-binding assay
Costar 9018 high-binding, 96-well plates (Corning, Corning, NY, USA) were coated overnight at 4°C with 10 g/ml mannan (M-7504; Sigma-Aldrich), dissolved in 100 mM sodium bicarbonate buffer (pH 9.6). The experiment was carried out at RT with 100 l/well unless indicated otherwise. After removal of the coating buffer, the wells were washed three times with washing buffer (10 mM Tris-HCl, pH 7.4, 0.9% NaCl, 5 mM CaCl 2 ) and blocked with 1% BSA in washing buffer for 1 h, followed by the washing procedure. rhSP-D (1 g/ml), in washing buffer, was mixed with LAIR-2-Fc or SIRL-Fc (both 0.5 g/ml) or buffer only, and after preincubation for 1 h in solution, the mixtures were applied to the mannan-coated plates. After 1 h incubation, plates were washed. SP-D detection involves incubation for 1 h with rabbit anti-hSP-D polyclonal serum (1:1000) [26] , washing, and 1-h incubation with goat anti-rabbit HRP (Nordic Immunological Laboratories, Eindhoven, the Netherlands). hFc detection involves incubation with rabbit anti-mouse F(ab=) 2 HRP. After a final wash, 100 l stabilized TMB chromogen (Life Technologies Europe BV, Bleiswijk, the Netherlands) was added. After color development, the reaction was stopped by adding 50 l 2 M H 2 SO 4 . Absorbance was measured at 450 nm. Background values were obtained for all conditions in the absence of mannan coating or in the presence of 5 mM EDTA during SP-D incubation. Data are expressed as relative intensities compared with incubation with SP-D only (goat anti-rabbit HRP signal set to 100%) or with incubation with SP-D, followed by LAIR-2 incubation (rabbit anti-mouse Fab 2 HRP signal set to 100%).
LAIR-1 reporter assay
2B4 NFAT-GFP TCRs stably expressing LAIR-1-CD3 chimeric receptors were used to detect functional LAIR-1 ligand binding as described before [16] .
Flow cytometry
Cells were stained with PE-labeled ␣-hLAIR-1 or a PE-labeled isotype control (BD PharMingen, San Diego, CA, USA) for 30 min in FACS buffer (PBS supplemented with 10 mg/ml BSA and 0.1% w/v sodium azide) at 4°C. Cells were washed three times with ice-cold FACS buffer and analyzed on an LSRII FACS using FACSDiva software (BD Biosciences, San Jose, CA, USA).
Oxidative burst assay
ROS production was measured using Amplex Red, as described before [28] , with minor adjustments. Statistical analysis was performed using SPSS software.
Western blot analysis
Matured PLB-985 cells were lysed in lysis buffer [50 mM Tris, 0.5 mM EDTA, 0.015 mM NaCl, 0.2 mM NaVO 3 , 1% Triton (v/v), and 0.25% Nadeoxycholate], and samples were subjected to SDS-PAGE. Proteins were transferred to Immobilon-P membranes (Millipore, Billerica, MA, USA) and detected using anti-hLAIR-1 or anti-tubulin and HRP-conjugated secondary antibodies. Amersham ECL Prime Western blotting detection reagent (GE Healthcare) was used to visualize bound antibodies.
RESULTS AND DISCUSSION
SP-D binds LAIR proteins with high-affinity
We applied several techniques to establish if SP-D binds to LAIR proteins and to deduce which domain of SP-D would be involved in this interaction (Fig. 1) . rLAIR-1, as well as LAIR-2, bound directly to immobilized, full-length SP-D (Fig. 1C) . The presence of 10 mM EDTA ruled out Ca ϩϩ -dependent interactions of the CRDs of SP-D (Fig. 1C) . The amount of LAIR-1 needed to reach the same ODs was 16ϫ higher than that for LAIR-2, indicating a lower affinity of SP-D for LAIR-1 than for LAIR-2, in line with our previous study showing a higher affinity of LAIR-2 for collagens [25] . Binding of LAIR proteins to SP-D was slightly lower than binding to collagen I. To characterize further the binding mechanism of LAIR to SP-D, we also tested a SP-D-mutant that lacks the collagenous domain (rhNCRD; Fig. 1B) for LAIR binding. rhNCRD is a NCRD trimer and binds sugars (data not shown). We observed no LAIR binding to rhNCRD (Fig. 1C) . From these data, we can conclude that the binding sites for the LAIR-1 and LAIR-2 proteins are located in the collagenous domain of SP-D. 
Olde Nordkamp et al. SP-D is a novel ligand for LAIR-1
Equilibrium binding data obtained with surface plasmon resonance studies showed that LAIR-2-HIS monomers bind to SP-D with moderate affinity (Fig. 1D and Table 1 ). We showed previously that the affinity for collagens I, III, and IV is ϳ2 M. Therefore, LAIR-2 binds to SP-D with a somewhat higher affinity than to collagen. The affinity of dimeric LAIR-2-Fc (0.037Ϯ0.002 M) is in the same range as the affinity of LAIR-2-Fc for collagen I (0.032Ϯ0.003 M; Fig. 1E and Table 1 ) [25] . Scatchard plots of the binding of LAIR-2-HIS and LAIR-2-Fc to SP-D are shown in Supplemental Fig. 1 . LAIR-1 protein also binds immobilized SP-D (Fig. 1C) , but we were unable to determine the affinity of LAIR-1 proteins for SP-D, as no binding to SP-D in the surface plasmon resonance assay was observed. Previously, we have shown that LAIR-2 has more and different binding sites on collagen than LAIR-1 [18] . The lack of LAIR-1 binding in the surface plasmon resonance assay might be a result of differences in the conformation of SP-D after binding to the CM5 chip compared with plastic, which blocks the LAIR-1-binding sites. In conclusion, SP-D binds rLAIR-1 and rLAIR-2 in a Ca ϩϩ -independent manner in an ELISA setting, and dimeric LAIR-2-Fc does so with high-affinity in surface plasmon resonance assays.
SP-D binding to LAIR does not interfere with the mannan-binding site of SP-D
The soluble protein LAIR-2 was previously found to have a higher affinity for collagen than soluble LAIR-1 [25] . To investigate the effect of binding of LAIR-2 to SP-D on the opsonin function of SP-D, SP-D was preincubated with LAIR-2-Fc or SIRL-1-Fc as a control inhibitory receptor, which does not bind collagen [24, 25] and added to solid-phase mannan ( 
SP-D functionally engages LAIR-1
We used cells expressing chimeric transmembrane proteins, consisting of the extracellular part of LAIR-1, fused to the intracellular part of the CD3 and a NFAT-GFP reporter to investigate if binding of cell-expressed LAIR-1 to the collagen domain of SP-D could also functionally ligate the receptor (Fig. 2A) . We used this assay previously to demonstrate functional binding of collagens and collagen-derived peptides to LAIR-1 [18] . As a control, we used cells only containing the NFAT-GFP reporter construct (WT cells) or cells expressing a chimera of SIRL-1 and the reporter construct [24] . Cells were incubated overnight with solid-phase collagen I, SP-D, or BSA (as a control), and GFP expression was assessed by flow cytometry (Fig. 2A) 
SP-D inhibits ROS production through LAIR-1
ROS production by neutrophils and monocytes is an important part of the defense mechanism against pathogens by the innate immune system, although it can also cause severe tissue damage when released into the extracellular milieu [29] . The effect of LAIR-1 ligation on ROS production was not studied previously.
To measure the extracellular ROS production, we have performed Amplex Red assays. We activated PLB-985 cells, which were matured with DMF toward a granulocytic lineage via the Fc␣R, to induce an oxidative burst. First, we tested whether ligation of LAIR-1 via collagen regulates this oxidative burst. Collagens II and III have multiple binding sites for LAIR-1. We previously identified trimeric collagen peptides that do (III-38) or do not (II-20) induce inhibitory signaling via LAIR-1 [18] . Simultaneous ligation of Fc␣R and LAIR-1 via collagen peptide III-38 reduced the oxidative burst by 50%, whereas collagen peptide II-20 did not significantly affect the oxidative burst ( Fig. 3A and  B) . Blockade of the LAIR-1-collagen interaction with specific F(ab=) 2 fragments significantly reversed the inhibition of the oxidative burst, demonstrating that the inhibition is LAIR-1-mediated ( Fig. 3A and B) . F(ab=) 2 fragments alone, in combination with IgA (data not shown) or in combination with IgA and collagen peptide II-20, did not significantly affect ROS production ( Fig. 3A and B) . Thus, LAIR-1 ligation through collagen inhibits the Fc␣R-induced oxidative burst. Next, we tested SP-D for its ability to inhibit ROS production in this setup. As a control, we used the rhNCRD peptide that does not bind LAIR-1 (Fig. 1B) . SP-D significantly inhibited the Fc␣R-induced oxidative burst in a concentration-dependent manner, up to 60%, whereas rhNCRD did not (Fig. 3C and D) . LAIR-1-specific F(ab=) 2 fragments prevented SP-D-mediated inhibition of ROS production, whereas addition of F(ab=) 2 fragments to rhNCRD did not (Fig. 3D) , indicating that SP-D inhibits the ROS production via LAIR-1.
To confirm further that the SP-D-mediated inhibition of the oxidative burst is LAIR-1-mediated, we constructed a LAIR-1 knockdown cell line by using shRNA specific for LAIR-1 [22] , which resulted in a decreased LAIR-1 surface expression (Fig. 4A) . The decrease in LAIR-1 expression in the knockdown cell line was verified on protein level by Western blot analysis (Fig. 4B) . We compared the knockdown cell line with the WT cell line in the same experimental setup, as described above. Although SP-D, like collagen peptide III-38, is still able to inhibit the Fc␣R-induced oxidative burst, the inhibition in the LAIR-1 knockdown cell line was significantly lower than in the WT cell line (Fig. 4C  and D) . This confirmed that the inhibitory action of SP-D is mediated, at least in part, by LAIR-1 (Fig. 4D) . Oxidative burst levels were not completely restored to the condition without SP-D added, which is in agreement with low-level LAIR expression, still observed in the knockdown cell line in Fig. 4A and B. SP-D has several immunomodulatory functions. However, the mechanisms via which SP-D exerts these functions are incompletely understood. In this study, we assessed the possibility that these functions are partially mediated by the inhibitory immune receptor LAIR-1. We show collagen domain-specific, Ca In the lung, SP-D functions as a first-line defense molecule by opsonizing pathogens [30] . As LAIR binding to SP-D does not hinder its mannan-binding function, we speculate that SP-D can function as an opsonin without mounting a fulminant immune response.
Alveolar macrophages of SP-D Ϫ/Ϫ mice show a tenfold higher production of hydrogen peroxide, as well as an increase in lipid peroxide in lung homogenates compared with WT mice [31] . In view of our data, this may reflect a lack of immune regulation in the lung via LAIR-1 and/or other inhibitory receptors. In line with this, attempts to rescue the phenotype of the SP-D Ϫ/Ϫ mice by intranasal delivery or overexpression of rSP-D fragments revealed that a fragment without the collagenous domain does not display therapeutic effects. Thus, the collagenous domain is involved in the immunomodulatory function of SP-D (reviewed in ref. [8] ), for which we now show that LAIR-1 is a receptor.
SP-D has been shown to function as a chemoattractant for neutrophils [32] . Previously, we showed that neutrophils express LAIR-1 upon activation [33] . Now, we show that SP-D can also functionally reduce the production of ROS via LAIR-1 signaling in a neutrophilic cell line. This may be important to limit damage to the lungs during pathogen clearance. SP-D was first found in lung lavage. Therefore, most studies were devoted to investigate the role of SP-D in pulmonary infections and inflammation. However, SP-D is expressed in many tissues and serves a more general role in the protection of mucosal epithelia. It will be interesting to study its putative, anti-inflammatory function in the gastrointestinal tract and other tissues [1, 34] .
Our data reveal a novel immunomodulatory axis, through which SP-D exerts its functions in steady-state and inflammatory conditions. Previously, Gardai et al. [11] showed CRD-dependent binding of SP-D to SIRP␣, which induces SHIP-1 activity and suppresses the capacity of alveolar macrophages to ingest apoptotic cells. They propose a model in which SP-D binds SIRP␣ via its CRD domains in the resting lung and after pathogen binding, activates the immune system by binding calreticulin/CD91 with its collagenous domain [35] . Our data show that the collagenous domains of SP-D can also inhibit immune activation via LAIR-1. Thus, SP-D dampens the inflammatory response mediated by immune cells, not only through its CRD domain via SIRP␣ but also via LAIR-1 through its collagenous domain.
We found a novel, functional receptor for SP-D that can dampen immune cell function in mucosal areas that are continuously exposed to pathogens and other triggers. Binding of SP-D via its collagenous domains to LAIR-1 may provide a mechanism for the unexplained immunomodulatory function of the collagenous domains of SP-D. We reveal a novel level of immune regulation that could contribute to lung homeostasis and prevents excessive inflammation and ROS production and thus, damage to the fragile lung epithelium. 
